Division of Transfusion Medicine

Publications

Recent

  1. Bloch EM, Levin AE, Williamson PC, Cyrus S, Shaz B, Kessler D, Gorlin J, Bruhn R, Lee TH, Montalvo L, Busch MP. A prospective evaluation of chronic B. microti infection in seroreactive blood donors. Transfusion. 2016 Jul;56(7):1875-82.
  2. Bloch EM, Mast AE, Josephson CD, Klein HG, Eder AF. Teenage Blood Donors: Are We Asking Too Little and Taking Too Much? Pediatrics 2017 Apr;139(4). pii: e20162955.
  3. Bloch EM, Simon MS, Shaz BH. Emerging infections and blood safety in the 21st century. Ann Intern Med. 2016 July;165(1):57-8.
  4. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, Gernsheimer T, Holcomb JB, Kaplan LJ, Katz LM, Peterson N, Ramsey G, Rao SV, Roback JD, Shander A, Tobian AA. Clinical Practice Guidelines from the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA 2016 Nov 15;316(19):2025-35.
  5. Chen I, Chau G, Wang J, Clarke W, Marzinke M, Cummings V, Breaud A, Laeyendecker O, Fields SD, Griffith S, Scott HM, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, and Eshleman SH. Analysis of HIV diversity in HIV-infected Black men who have sex with men (HPTN 061). PLoS One 2016 Dec;11(12):e0167629.
  6. Chen I, Huang W, Connor MB, Frantzell A, Cummings V, Beauchamp GG, Griffith S, Fields SD, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Tieu HV, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. CXCR4-using HIV variants in a cohort of Black men who have sex with men: HIV Prevention Trials Network 061. HIV Clin Trials. 2016 Jul;17(4):158-64.
  7. Eshleman SH, Hudelson SE, Redd AD, Cohen MS. Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial. J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):112-6.
  8. Eshleman SH, Wilson EA, Zhang XC, Ou S-S, Piwowar-Manning E, Eron JJ, McCauley Marybeth, Gamble T, Gallant JE, Hosseinipour MC, Kumarasamy N, Hakim JG, Kalonga B, Pilotto JH, Grinsztejn B, Godbole SV, Chotirosniramit N, Santos BR, Shava E, Mills LA, Panchia R, Mwelase N, Mayer KH, Chen YQ, Cohen MS, Fogel JM. Virologic outcomes in early antiretroviral treatment: HPTN 052. HIV Clin Trials. 2017 May;18(3):100-9.
  9. Fogel JM, Clarke W, Kulich M, Piwowar-Manning E, Breaud A, Olson MT, Marzinke MA, Laeyendecker O, Fiamma A, Donnell D, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH. Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043). J Acquir Immune Defic Syndr 2017 Feb 1;74(2):158-65.
  10. Fogel JM, Santos BR, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Mayer KH, Chen YQ, Cohen MS, Eshleman SH. HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial. J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):304-9.
  11. Gehrie EA. Transfusion support in acute leukemia: what is the evidence to support routine practices? Transfusion. 2017 Feb;57(2):229-33.
  12. Gehrie EA, Tobian AAR. Editorial: Plasma transfusion as bleeding prophylaxis in the critically ill. Anesth Analg. 2017 May;124(5):1385-6.
  13. Gniadek TJ, McGonigle AM, Shirey RS, Brunker PA, Streiff M, Philosophe B, Bloch EM, Ness PM, King KE. A rare, potentially life-threatening presentation of passenger lymphocyte syndrome. Transfusion. 2017 May;57(5):1262-6.
  14. Grabowski MK, Gravitt PE, Gray RH, Serwadda D, Redd AD, Kigozi G, Kong X, Nalugoda F, Wawer MJ, Quinn TC, Tobian AAR. Trends and determinants of human papillomavirus concordance among human immunodeficiency virus-positive and -negative heterosexual couples in Rakai, Uganda. J Infectious Diseases 2017 March;215(5):772-80.
  15. Hume HA, Ddungu H, Angom R, Baluku H, Kajumbula H, Kyeyune-Byabazaire D, Orem J, Ramirez-Arcos S, Tobian AA. Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions. Transfusion 2016 Aug;56(8):1951-9.
  16. Jimenez A, Shaz BH, Bloch EM. Zika Virus and the Blood Supply: What Do We Know? Transfus Med Rev. 2017 Jan;31(1):1-10.
  17. Morar MM, Pitman J, McFarland W, Bloch EM. The Contribution of Unsafe Blood Transfusion to HIV Incidence in sub-Saharan Africa: Re-examination of the 5% to 10% Convention. Transfusion 2016 Dec;56 (12):3121-32.
  18. Palumbo P, Wilson EA, McCauley M, Gamble T, Kumwenda N, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim JG, Hosseinipour MC, Gonçalves de Melo M, Pilotto JH, Grinsztejn B, Panchia R, Chen YQ, Cohen MS, Eshleman SH, Fogel JM. Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052. PLoS One 2017 May 8;12(5):e0177281.
  19. Patel EU, Kirkpatrick AR, Grabowski MK, Kigozi G, Gray RH, Prodger JL, Redd AD, Nalugoda F, Serwadda D, Wawer MJ, Quinn TC, Tobian AAR. Penile immune activation and risk of HIV shedding: a prospective cohort study. Clin Infect Dis 2017 Mar;64(6):776-84.
  20. Patel EU, Rositch AF, Gravitt PE, Tobian AAR. Concordance of Penile and Oral Human Papillomavirus Infections Among Men in the United States. J Infect Dis. 2017 Apr;215(8):1207-11.
  21. Plourde A, Bloch EM. A Literature Review of Zika Virus. Emerg Infect Dis. 2016 July;22(7):1185-92.
  22. Tamma PD, Opene BN, Gluck A, Chambers KK, Carroll KC, Simner PJ. Comparison of 11 Phenotypic Assays for Accurate Detection of Carbapenemase-Producing Enterobacteriaceae. J Clin Microbiol 2017 Apr;55(4):1046-55.
  23. Tobian AA, Ness PM. Editorial- Red blood cells: aging gracefully in the blood bank. N Engl J Med 2016 Nov;375:1995-7.
  24. Tobian AAR, Ness PM. Short-term versus long-term blood storage. N Engl J Med 2017;376:1093-4. (reply to letter to the editor).

2016

  1. Glynn SA, Klein HG, Ness PM. The red blood cell storage lesion: the end of the beginning. Transfusion 2016 June;56(6):1462-8.
  2. Kantor R, Smeaton L, SH Eshleman: AIDS Clinical Trials Group (ACTG) A5175 Study Team. Pre-treatment HIV drug resistance and HIV-1 subtype Care independently associated with virologic failure: Results from the multi-national PEARLS (ACTG A5175) clinical trial. Clin Infect Dis 2015 May;60(10):1541-9.
  3. Goel R, King KE, Takemoto CM, Ness PM, Tobian AA. Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012. Transfusion. 2016 Jun;56(6):1451-8.
  4. Heddle NM, Ness PM. CONSORT and clinical trial reporting: room for improvement. Transfusion. 2016 Apr;56(4):781-3.
  5. Thompson ED, Stelow EB, Mills SE, Westra WH, Bishop JA. Large cell neuroendocrine carcinoma of the head and neck: a clinicopathologic series of 10 cases with an emphasis on HPV status. Am J Surg Pathol 2016 Apr;40(4):471-8.
  6. Tobian AAR, Reed J, Njeuhmeli E. An evidence-based analysis of voluntary medical male circumcision devices. Nat Rev Urol 2016 May;13(5):295.
  7. Grabowski MK, Kong X, Gray RH, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Reynolds SJ, Wawer MJ, Redd AD, Watya S, Quinn TC, Tobian AAR. Partner human papillomavirus viral load and incident human papillomavirus detection in heterosexual couples. J Infect Dis 2016 Mar;213(6):948-56.
  8. Hulse M, Fader AN, Shan H, Benneh N, Tobian AAR. Massive transfusion in an obstetric emergency. Transfusion 2016 Jan;56:23.
  9. Kaufman MR, Smelyanskaya M, Van Lith LM, Mallalieu B, Waxman A, Hatzhold K, Marcell AV, Kasedde S, Lija J, Hasen N, Ncube G, Samuelson JL, Bonnecwe C, Seifert-Ahanda K, Njeuhmeli E, Tobian AAR. Adolescent sexual and reproductive health services and implications for the provision of voluntary medical male circumcision: results of a systematic review of literature. PLoS One 2016 Mar;11(3):e0149892.

2015

  1. Chen I, Connor MB, Clarke W, Marzinke MA, Cummings V, Breaud A, Fogel JM, Laeyendecker O, Fields SD, Donnell D, Griffith S, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. Antiretroviral drug use and HIV drug resistance among HIV-infected Black men who have sex with men: HIV Prevention Trials Network 061. J Acquir Immune Defic Synd. 2015 Aug;69(4):446-52.
  2. Chen I, Ou S-S, Marzinke MA, Breaud A, Hughes JP, Richardson, P, Haley DF, Lucas J, Rompalo A, Justman JE, Hodder SA, Eshleman SH. Antiretroviral drug use in a cohort of HIV-uninfected women in the United States: HIV Prevention Trials Network 064. PLoS One 2015 Oct 7;10(10):e0140074.
  3. Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH. Determination of HIV status in African adults with discordant HIV rapid tests. J Acquir Immune Defic Syndr 2015 Aug;69(4):430-8.
  4. Goel R, Ness PM, Takemoto C, King KE, Krishnamurti L, Tobian AAR. Platelet transfusions in platelet consumptive disorders are associated with in-hospital arterial thrombotic complications and mortality. Blood 2015; 125(9):1470-6.
  5. Grabowski MK, Gray RH, Makumbi F, Kagaayi J, Redd AD, Kigozi G, Reynolds SJ, Nalugoda F, Lutalo T, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR. Use of injectable hormonal contraception and women's risk for herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda. Lancet Global Health 2015 Aug;3:e478-86.
  6. Grabowski MK, Kigozi G, Gray RH, Armour B, Manucci J, Serwadda D, Redd AD, Nalugoda Patel EU, Wawer MJ, Quinn TC, Tobian AAR. Herpes simplex virus type 2 shedding from male circumcision wounds in Rakai Uganda. J Infect Dis 2015 Nov 15;212(10):1613-7.
  7. Kacker S, Ness PM, Shirey RS, Savage WJ, King KE, Tobian AAR. The future of red blood cell alloimmunization risk reduction. Transfusion 2015 Jan;55(1):222-4.
  8. Kacker S, Vassallo R, Keller MA, Westhoff CM, Frick KD, Sandler SG, Tobian AA. Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype. Transfusion. 2015 Sep;55(9):2095-103.
  9. Kantor R, Smeaton L, SH Eshleman: AIDS Clinical Trials Group (ACTG) A5175 Study Team. Pre-treatment HIV drug resistance and HIV-1 subtype Care independently associated with virologic failure: Results from the multi-national PEARLS (ACTG A5175) clinical trial. Clin Infect Dis 2015 May;60(10):1541-9.
  10. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, Cipolle MD, Cohn CS, Fung MK, Grossman BJ, Mintz PD, O'Malley BA, Sesok-Pizzini DA, Shander A, Stack GE, Webert KE, Weinstein R, Welch BG, Whitman GJ, Wong EC, Tobian AAR. Platelet transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 2015 Feb;162:205-13.
  11. Ness PM, English J. TRANSFUSION enhancements in the digital age. Transfusion 2015 Jan;55(1):10.
  12. Ness PM, Frank SM. Enhancing patient blood management: a long term FOCUS. The Lancet 2015 Mar;385(9974):1157-9.
  13. Pagano MB, Ness PM, Chajewski OS, King KE, Wu Y, Tobian AA. Hypotensive transfusion reactions in the era of prestorage leukoreduction. Transfusion 2015 Jul;55(7):1668-74.
  14. Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke M, Fiamma A, Donnell D, Kulich M, Mbwambo JKK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH. Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Africa. J Clin Virol 2015 Jan;62:75-9.
  15. Tobian AAR, Adamu T, Reed J, Kiggundu V, Yazdi Y, Njeuhmeli E. Voluntary medical male circumcision: moving from evidence to policy to scale-up in resource constrained settings. Nature Reviews Urology Dec 2015;12:661-70.
  16. Tobian AAR, Kigozi G, Manucci J, Grabowski MK, Serwadda D, Musoke R, Redd AD, Nalugoda F, Reynolds SJ, Kighoma N, Laeyendecker O, Lessler J, Gray RH, Quinn TC, Wawer MJ and the Rakai Health Sciences Program. HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study. PLoS Medicine 2015;12(4):e1001820.
  17. Westhoff CM, Ness PM. The promise of extended donor antigen typing. Transfusion. 2015 Nov;55(11):2541-3.
  18. White MJ, Hazard SW 3rd, Frank SM, Boyd JS, Wick EC, Ness PM, Tobian AA. The evolution of perioperative transfusion testing and blood ordering. Anesth Analg 2015 Jun;120(6):1196-203.
  19. Yang B, Yang A, Peng S, Pang X, Roden RB, Wu TC, Hung CF. Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination. Cell Biosci 2015 Jun 25;5:35.